Lexmark Pharmaceuticals Private Limited, a active private limited company, was established on 10 October 2013 in Unjha, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230GJ2013PTC077157. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kalpeshkumar Mahendrabhai Dave (Director), Ramilaben Amrutlal Raval (Director). It holds ₹5.00 M open charges and ₹7.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 778, Paiki, At Post Karanpur, Taluka- Unjha, Dist.:Mahesana, Unjha, Gujarat, 384170.
U24230GJ2013PTC077157
077157
10 October 2013
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Lexmark Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalpeshkumar Mahendrabhai Dave | Director | 10 Oct 2013 | Current |
| Ramilaben Amrutlal Raval | Director | 10 Oct 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lexmark Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.06% decrease. The company also saw a slight improvement in profitability, with a 7.47% increase in profit. The company's net worth Soared by an impressive increase of 30.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lexmark Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹7,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2021 | Sidbi | ₹5.00 M | Open |
| 26 Oct 2020 | Hdfc Bank Limited | ₹7.50 M | Satisfied |
Explore comprehensive loan charge details -
Lexmark Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lexmark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lexmark Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lexmark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Lexmark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The activity A charge with Sidbi amounted to Rs. 5.00 M with Charge ID 100483208 was registered on 27 Sep 2021. was completed.
Progress on A charge registered on 26 Oct 2020 via Charge ID 100406235 with Hdfc Bank Limited was fully satisfied on 15 Sep 2021. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.50 M with Charge ID 100406235 was registered on 26 Oct 2020. was documented.
The activity Kalpeshkumar Mahendrabhai Dave was appointed as a Director was appointed as a Director on 10 Oct 2013 & has been associated with this company since 12 years 2 months . was completed.
The CIN of Lexmark Pharmaceuticals Private Limited is U24230GJ2013PTC077157.
Lexmark Pharmaceuticals Private Limited is headquartered at 778, Paiki, At Post Karanpur, Taluka- Unjha, Dist.:Mahesana, Unjha, Gujarat, 384170.
Lexmark Pharmaceuticals Private Limited was incorporated on 10 October 2013.
The current directors of Lexmark Pharmaceuticals Private Limited are
The primary industry of Lexmark Pharmaceuticals Private Limited is Trade.
Lexmark Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lexmark Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Lexmark Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX